Showing results (61-70 of 468) with videos related to
Sort By:
Pageof 47
Nature Clinical Practice. Oncology|November 3, 2005
Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practiceEdith D Canby-Hagino, Ian M ThompsonUrology Practice|June 14, 2023
Local Antibiogram Predicts Appropriate Antibiotic Selection for Prostate Biopsy ProphylaxisElizabeth Rourke, Steven Madsen, Andrea Yunes, et al.The Prostate|November 25, 2014
Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimensGregory P Swanson, Jonathan I Epstein, Chul S Ha, et al.Urologic Oncology|December 13, 2003
Histologic confirmation of lesions identified by Prostascint scan following definitive treatmentCarlos E Bermejo, John Coursey, Joseph Basler, et al.Current Urology Reports|May 5, 2005
Biomarkers for the detection and prognosis of prostate cancerJavier Hernandez, Edith Canby-Hagino, Ian M ThompsonUrologic Oncology|April 10, 2003
Serendipitous renal cell carcinoma in the post-CT era: continued evidence in improved outcomesJeffrey A Leslie, Tom Prihoda, Ian M ThompsonThe Journal of Urology|January 10, 2004
Prostate cancer chemoprevention: an overview of United States trialsAlbaha Barqawi, Ian M Thompson, E David CrawfordClinical Interventions in Aging|December 1, 2007
Role of 5 alpha-reductase inhibitors in the management of prostate cancerSteven J Hudak, Javier Hernandez, Ian M ThompsonAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Evolving Recommendations on Prostate Cancer ScreeningOtis W Brawley, Ian M Thompson, Henrik GrönbergThe Urologic Clinics of North America|May 5, 2004
The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditionsJavier Hernandez, Joseph W Basler, Ian M ThompsonPageof 47